Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Chokri Ben Lamine: Routine VTE Prophylaxis Is Not Recommended for Chronically Bedridden Patients at Home
AI generated
Apr 6, 2026, 10:49

Chokri Ben Lamine: Routine VTE Prophylaxis Is Not Recommended for Chronically Bedridden Patients at Home

Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on X:

“Short answer (guideline-based): NO routine VTE prophylaxis for chronically bedridden patients at home.

Guideline Position

American College of Chest Physicians (CHEST Guidelines)

Do Not recommend pharmacologic prophylaxis for:

  • Chronically immobilized patients
  • Nursing home residents
  • Home-bound patients without acute illness

Rationale:

  • Lower VTE incidence vs hospitalized patients
  • Higher bleeding risk outweighs benefit

American Society of Hematology (ASH 2018/2021 VTE Guidelines)

Suggest against routine prophylaxis in:

  • Long-term immobile patients at home
  • Unless additional strong transient risk factors present

When to Consider prophylaxis (exception cases)

Only if HIGH-RISK transient state, e.g.:

  • Recent hospitalization (≤45–90 days)
  • Active cancer (especially receiving chemotherapy)
  • Prior VTE
  • Acute infection or inflammation
  • Marked reduced mobility with additional risk (Improce score high)

In such cases, short-term prophylaxis may be considered on a case-by-case basis.

Extended prophylaxis trials (important nuance)

  • MAGELLAN trial
  • APEX trial
  • MARINER trial

Show benefit in selected high-risk recently hospitalized patients, Not applicable to stable chronically bedridden home patients

Practical Hematology Take

  • Bedridden status alone is not an indication
  • Always balance: VTE risk vs bleeding risk
  • Focus on:
  1. Hydration
  2. Mobilization if possible
  3. Reassess if clinical status changes

Key References

  • Kahn SR et al. CHEST Guideline (2012, updated concepts)
  • Spyropoulos AC et al., MARINER Trial (NEJM 2018)
  • Cohen AT et al., MAGELLAN Trial (NEJM 2013)

One-line clinical answer

No routine pharmacologic VTE prophylaxis for chronically bedridden patients at home unless additional high-risk transient factors are present.”

Stay updated with Hemostasis Today.

APEX trial Chokri Ben Lamine Health Hematology Hemostasis Hemostasis News Hemostasis Today MAGELLAN trial MARINER trial Medicine thrombosis VTE
NewsFeed